See more : RGC Resources, Inc. (RGCO) Income Statement Analysis – Financial Results
Complete financial analysis of ViviCells International, Inc. (VCII) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ViviCells International, Inc., a leading company in the Renewable Utilities industry within the Utilities sector.
- United American Healthcare Corporation (UAHC) Income Statement Analysis – Financial Results
- Fortis Malar Hospitals Limited (FORTISMLR.BO) Income Statement Analysis – Financial Results
- Asax Co., Ltd. (8772.T) Income Statement Analysis – Financial Results
- Soluciones Cuatroochenta S.L. (480S.MC) Income Statement Analysis – Financial Results
- The Hilliard Corporation (HLRD) Income Statement Analysis – Financial Results
ViviCells International, Inc. (VCII)
About ViviCells International, Inc.
ViviCells International, Inc. operates as a stem cell preservation company. ViviCells International, Inc. was formerly known as Tropical Beverage Inc. and changed its name to ViviCells International, Inc. in May 2008. The company was incorporated in 1995 and is based in Evanston, Illinois.
| Metric | 2019 | 2018 | 2017 | 2016 | 1999 |
|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 4.24M |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 2.73M |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 1.51M |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 35.66% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 5.19K | 1.59K | 2.79K | 6.45K | 1.60M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 5.19K | 1.59K | 2.79K | 6.45K | 1.60M |
| Cost & Expenses | 5.19K | 1.59K | 2.79K | 6.45K | 4.33M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 882.57K |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 511.45K |
| Depreciation & Amortization | 171.86K | 0.00 | 0.00 | 0.00 | 34.80K |
| EBITDA | -5.19K | -1.59K | -2.78K | -6.45K | 762.82K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -1.34% |
| Operating Income | -5.19K | -1.59K | -2.78K | -6.45K | -91.78K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -2.17% |
| Total Other Income/Expenses | 1.00 | -2.00 | -5.00 | -2.00 | 308.34K |
| Income Before Tax | -5.19K | -1.59K | -2.79K | -6.45K | 216.56K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 5.11% |
| Income Tax Expense | -171.86K | 0.00 | 0.00 | 0.00 | 231.00K |
| Net Income | -5.19K | -1.59K | -2.79K | -6.45K | -14.44K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -0.34% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | -55.26 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -55.26 |
| Weighted Avg Shares Out | 113.88M | 113.88M | 113.88M | 113.88M | 261.27 |
| Weighted Avg Shares Out (Dil) | 113.88M | 113.88M | 113.88M | 113.88M | 261.27 |
Source: https://incomestatements.info
Category: Stock Reports